Evidence map›Paper›PMID 24227772›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2013

MicroRNA-155 tunes both the threshold and extent of NK cell activation via targeting of multiple signaling pathways.

Ryan P Sullivan, Leslie A Fogel, Jeffrey W Leong, Stephanie E Schneider, Rachel Wong, Rizwan Romee, To-Ha Thai, Veronika Sexl, Scot J Matkovich, Gerald W Dorn and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 58 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. miRNAs in NK Cell-Based Immune Responses and Cancer Immunotherapy.Frontiers in cell and developmental biology · 2020
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Ryan P SullivanDivision of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110;
Leslie A Fogel
Jeffrey W Leong
Stephanie E Schneider
Rachel Wong
Rizwan Romee
To-Ha Thai
Veronika Sexl
Scot J Matkovich
Gerald W Dorn
Anthony R French
Todd A Fehniger
Washington University in St. Louis · USHarvard University · USUniversity of Vienna · AT

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
Viral Discovery in Rheumatoid ArthritisP30AR048335 · NIAMS · WASHINGTON UNIVERSITY · PI BYUN, MINJI · 2001 to 2015
$8.9M
REGULATION OF VIRAL-INDUCED NK CELL PROLIFERATION DURING MURINE CMV INFECTIONR01AI078994 · NIAID · WASHINGTON UNIVERSITY · PI FRENCH, ANTHONY R · 2009 to 2019
$3.8M
MICRORNA REGULATION OF NK CELL DEVELOPMENT AND FUNCTIONR01AI102924 · NIAID · WASHINGTON UNIVERSITY · PI FEHNIGER, TODD A · 2013 to 2016
$1.5M
MICRORNA TARGETING IN HEART FAILURER01HL108943 · NHLBI · WASHINGTON UNIVERSITY · PI DORN, GERALD W. · 2012 to 2015
$1.5M
Molecular Mechanisms of Natural Killer Cell Cytokine-ActivationK08HL093299 · NHLBI · WASHINGTON UNIVERSITY · PI FEHNIGER, TODD A · 2009 to 2013
$583k
Howard Hughes Medical InstituteNCI NIH HHS P30 CA091842NHLBI NIH HHS K08 HL093299NHLBI NIH HHS K08HL093299NHLBI NIH HHS R01 HL108943NHLBI NIH HHS T32 HL708836NIAID NIH HHS AI078994NIAID NIH HHS R01 AI078994NIAID NIH HHS R01 AI102924NIAID NIH HHS R01AI102924NIAMS NIH HHS P30 AR048335
6 · The paper itself

Abstract

NK cells are innate lymphocytes important for host defense against viral infections and malignancy. However, the molecular programs orchestrating NK cell activation are incompletely understood. MicroRNA-155 (miR-155) is markedly upregulated following cytokine activation of human and mouse NK cells. Surprisingly, mature human and mouse NK cells transduced to overexpress miR-155, NK cells from mice with NK cell-specific miR-155 overexpression, and miR-155(-/-) NK cells all secreted more IFN-γ compared with controls. Investigating further, we found that activated NK cells with miR-155 overexpression had increased per-cell IFN-γ with normal IFN-γ(+) percentages, whereas greater percentages of miR-155(-/-) NK cells were IFN-γ(+). In vivo murine CMV-induced IFN-γ expression by NK cells in these miR-155 models recapitulated the in vitro phenotypes. We performed unbiased RNA-induced silencing complex sequencing on wild-type and miR-155(-/-) NK cells and found that mRNAs targeted by miR-155 were enriched in NK cell activation signaling pathways. Using specific inhibitors, we confirmed these pathways were mechanistically involved in regulating IFN-γ production by miR-155(-/-) NK cells. These data indicate that miR-155 regulation of NK cell activation is complex and that miR-155 functions as a dynamic tuner for NK cell activation via both setting the activation threshold as well as controlling the extent of activation in mature NK cells. In summary, miR-155(-/-) NK cells are more easily activated, through increased expression of proteins in the PI3K, NF-κB, and calcineurin pathways, and miR-155(-/-) and 155-overexpressing NK cells exhibit increased IFN-γ production through distinct cellular mechanisms.

Indexed as

AnimalsCalcineurinCells, CulturedCytomegalovirus InfectionsGene Expression RegulationGenes, ReporterGenetic VectorsHumansInterferon-gammaInterleukinsKiller Cells, NaturalLentivirusLymphocyte ActivationMiceMice, Inbred C57BLMice, KnockoutCalcineurinInterferon-gammaInterleukinsMicroRNAsMIRN155 microRNA, humanMirn155 microRNA, mouseNF-kappa BPhosphatidylinositol 3-KinasesRecombinant Fusion Proteins

Identifiers

PMID24227772
PMCPMC3863634
OpenAlexW2125550288

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.